AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,470.00p
   
  • Change Today:
    -76.00p
  • 52 Week High: 12,940.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.70m
  • Volume: 1,076,537
  • Market Cap: £193,372m
  • RiskGrade: 123
  • Beta: 1.32

Latest Deals

Traded Action Notifier PriceAmountValue
09-Sep-25 Buy Karen Knudsen 11,983.78p 5 £599.19
14-Aug-25 Sell Aradhana Sarin 11,511.70p 9,563 £1,100,863.84
21-May-25 Transfer From Pascal Soriot 0.000p 8,970 £0.00
30-Apr-25 Buy Karen Knudsen 5,376.72p 1,400 £75,274.07
06-Mar-25 Transfer From Pascal Soriot 0.000p 89,962 £0.00
05-Mar-25 Buy Dividends Aradhana Sarin 0.000p 28 £0.00
05-Mar-25 Buy Dividends Pascal Soriot 0.000p 248 £0.00
04-Mar-25 Transfer From Aradhana Sarin 0.000p 2,021 £0.00
04-Mar-25 Transfer From Pascal Soriot 0.000p 17,357 £0.00
19-Nov-24 Buy Tony Mok 12,679.63p 1,500 £190,194.50
15-Nov-24 Buy Michel Demare 10,030.35p 2,000 £200,607.04
14-Nov-24 Buy Pascal Soriot 10,203.00p 20,000 £2,040,599.98
11-Nov-24 Buy Philip A J Broadley 10,169.91p 980 £99,665.11

Latest Notification of Holdings

No notifications of holding were found in the last 365 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,470.00p
Change Today -76.00p
% Change -0.61 %
52 Week High 12,940.00p
52 Week Low 9,667.00p
Volume 1,076,537
Shares Issued 1,550.70m
Market Cap £193,372m
Beta 1.32
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 9
Buy 13
Neutral 4
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 31-Oct-2025

Time Volume / Share Price
14:42 0 @ 12,524.00p
14:40 0 @ 12,522.00p
14:41 2 @ 12,518.00p
16:49 18 @ 12,470.00p
16:48 2 @ 12,470.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page